Melatonin not found to improve fatigue in patients with advanced cancer
the ONA take:
According to a new study published online ahead of print in the journal Cancer, researchers at Bispebjerg Hospital in Copenhagen, Denmark, have found use of oral melatonin at a dose of 20 mg was not associated with improvement in fatigue or other symptoms in patients with advanced cancer.
For the study, researchers sought to assess the effect of melatonin on fatigue and other symptoms in patients with advanced cancer. Researchers enrolled 72 patients with stage IV cancer who reported significant fatigue and randomly assigned them to receive 1 week of melatonin 20 mg or placebo orally each night. Patients then crossed over and received the opposite treatment for 1 week.
Of those, 50 patients completed the study and 44 were 100% compliant with the interventions. Results showed no difference in physical fatigue or other quality of life measures between melatonin and placebo.
Oral melatonin was not associated with improvement in fatigue or other symptoms in patients with advanced cancer.
- FDA Grants Approval to Bevacizumab-awwb as First Biosimilar for Anticancer Therapy
- Efficacy of Octreotide LAR, Lanreotide in Management of Carcinoid Tumors
- Multivitamin Use May Reduce Risk of Chemo-Induced Neuropathy
- Overall Survival in Advanced Melanoma Improved With Nivolumab, Ipilimumab Combination
- Adjuvant Durvalumab Therapy May Prolong Progression-free Survival in NSCLC
- Invisible Burdens: The Complex Needs of Caregivers of Patients With Brain Cancer
- Cannabis Reduces Response Rate to Immunotherapy for Cancer
- Perioperative Blockade of Pathways May Improve Outcomes in Breast Cancer
- Zika Virus Preferentially Targets Glioblastoma Stem Cells
- Daratumumab Infusion-Related Reactions Managed by Pre/Postinfusion Medications
- Lorazepam Plus Haloperidol Improves Agitation in Cancer-Related Delirium
- Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
- Treating Intractable Hiccups in Advanced Cancer, Palliative Care Setting
- Severe Mental Illness May Worsen Breast Cancer Survival Outcomes
- Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|